Erratum: “SFTA3, a novel protein of the lung: three-dimensional structure, characterisation and immune activation.” M. Schicht, F. Rausch, S. Finotto, et al.(European Respiratory Journal (2014) 44 (447–456) DOI: 10.1183/09031936.00179813);SFTA3, a novel protein of the lung: Three-dimensional structure, characterisation and immune activation

European Respiratory Journal

Volumn 44, Issue 2, 2014, Pages 447-456

  Schicht, Martin ^a   Rausch, Felix ^a   Finotto, Susetta ^a   Mathews, Martina ^a   Mattil, Anja ^a   Schubert, Melanie ^a   Koch, Beate ^a   Traxdorf, Maximilian ^a   Bohr, Christopher ^a   Worlitzsch, Dieter ^b   Brandt, Wolfgang ^c   Garreis, Fabian ^a   Sel, Saadettin ^d   Paulsen, Friedrich ^a   Bräuer, Lars ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^c LEIBNIZ INSTITUTE OF PLANT BIOCHEMISTRY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT ASSOCIATED PROTEIN 3; UNCLASSIFIED DRUG; CYTOKINE; SFTA3 PROTEIN, HUMAN; SURFACTANT;

A549 CELL LINE; ARTICLE; ASTHMA; BIOINFORMATICS; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE ACTIVATION; IMMUNE RESPONSE; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL PROCEDURES; IN VITRO STUDY; LUNG ALVEOLUS CELL TYPE 2; LUNG PARENCHYMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SEPSIS; SFTA3 GENE; CHEMISTRY; ELECTRON MICROSCOPY; EXON; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; MUCOSA; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN PROCESSING; TUMOR CELL LINE;

CELL LINE, TUMOR; CYSTIC FIBROSIS; CYTOKINES; EXONS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-23; LIPOPOLYSACCHARIDES; LUNG; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; MUCOUS MEMBRANE; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; SURFACE-ACTIVE AGENTS;

EID: 84905644409     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.51798-2013     Document Type: Erratum

References (31)

1. Halliday HL. Surfactants: past, present and future. J Perinatol 2008; 28: Suppl. 1, S47-S56. (Pubitemid 351622251)
2. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005; 5: 58-68. (Pubitemid 40070331)
3. Hartshorn KL, Crouch E, White MR, et al. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 1998; 274: L958-L969.
4. Kishore U, Greenhough TJ, Waters P, et al. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol 2006; 43: 1293-1315. (Pubitemid 43356370)
5. Ding J, Takamoto DY, von Nahmen A, et al. Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability. Biophys J 2001; 80: 2262-2272. (Pubitemid 32401991)
6. Cochrane CG, Revak SD. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 1991; 254: 566-568. (Pubitemid 21917374)
7. Bräuer L, Johl M, Börgermann J, et al. Detection and localization of the hydrophobic surfactant proteins B and C in human tear fluid and the human lacrimal system. Curr Eye Res 2007; 32: 931-938.
8. Bräuer L, Möschter S, Beileke S, et al. Human parotid and submandibular glands express and secrete surfactant proteins A, B, C and D. Histochem Cell Biol 2009; 132: 331-338.
9. Bräuer L, Schicht M, Stengl C, et al. Detection of surfactant proteins A, B, C and D in human gingiva and saliva. Biomed Tech (Berl) 2012; 57: 59-64.
10. Schicht M, Knipping S, Hirt R, et al. Detection of surfactant proteins A, B, C, and D in human nasal mucosa and their regulation in chronic rhinosinusitis with polyps. Am J Rhinol Allergy 2013; 27: 24-29.
11. Yang L, Johansson J, Ridsdale R, et al. Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH. J Immunol 2010; 184: 975-983.
12. Rausch F, Schicht M, Paulsen F, et al. "SP-G", a putative new surfactant protein - tissue localization and 3D structure. PLoS One 2012; 7: e47789.
13. Wright JR. Clearance and recycling of pulmonary surfactant. Am J Physiol 1990; 259: L1-L12. (Pubitemid 20257227)
14. Heilig R, Eckenberg R, Petit JL, et al. The DNA sequence and analysis of human chromosome 14. Nature 2003; 421: 601-607. (Pubitemid 36227662)
15. Reppert S, Boross I, Koslowski M, et al. A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer. Nat Commun 2011; 2: 600.
16. Wright JM, Merlo CA, Reynolds JB, et al. Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease. Am J Respir Cell Mol Biol 2006; 35: 327-336. (Pubitemid 44353401)
17. Noah TL, Murphy PC, Alink JJ, et al. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 685-691. (Pubitemid 37175970)
18. Barnett CP, Mencel JJ, Gecz J, et al. Choreoathetosis, congenital hypothyroidism and neonatal respiratory distress syndrome with intact NKX2-1. Am J Med Genet A 2012; 158A: 3168-3173.
19. Madsen J, Kliem A, Tornøe I, et al. Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 2000; 164: 5866-5870. (Pubitemid 30389831)
20. Parra E, Alcaraz A, Cruz A, et al. Hydrophobic pulmonary surfactant proteins SP-B and SP-C induce pore formation in planar lipid membranes: evidence for proteolipid pores. Biophys J 2013; 104: 146-155.
21. Golde DW, Territo M, Finley TN, et al. Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 1976; 85: 304-309.
22. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258: 1123-1142.
23. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002; 109: 707-712. (Pubitemid 34263144)
24. Muzio M, Bosisio D, Polentarutti N, et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000; 164: 5998-6004. (Pubitemid 30389848)
25. Väyrynen O, Glumoff V, Hallman M. Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung. Am J Physiol Lung Cell Mol Physiol 2002; 282: L803-L810.
26. Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 1999; 158: Suppl. 1, S18-S22.
27. Hybertson BM, Lee YM, Repine JE. Phagocytes and acute lung injury: dual roles for interleukin-1. Ann N Y Acad Sci 1997; 832: 266-273. (Pubitemid 28045320)
28. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88: 1976-1981.
29. Hallman M, Lappalainen U, Bry K. Clearance of intra-amniotic lung surfactant: uptake and utilization by the fetal rabbit lung. Am J Physiol 1997; 273: L55-L63.
30. Ben-Neriah Y, KarinM. Inflammationmeets cancer, with NF-kB as the matchmaker. Nat Immunol 2011; 12: 715-723.
31. Niimi T, Nagashima K, Ward JM, et al. Claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing. Mol Cell Biol 2001; 21: 7380-7390. (Pubitemid 32958540)